These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3070988)

  • 1. [After-care of melanoma. 8 years' experience using the Mainz model].
    Schramm P
    Z Hautkr; 1988 Oct; 63(10):816-21. PubMed ID: 3070988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant melanoma: which examinations are useful in staging and follow-up?].
    Goerz G; Schulte-Beerbühl R; Roder K; Schoppe WD; Münchhoff C; Jungblut RM
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1230-3. PubMed ID: 3527640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
    de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG
    Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
    Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
    Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study.
    Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Singnomklao T; Ringborg U
    Cancer; 1997 Oct; 80(8):1418-25. PubMed ID: 9338465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic progress in malignant melanomas by high-resolution real-time sonography].
    Kraus W; Nake-Elias A; Schramm P
    Hautarzt; 1985 Jul; 36(7):386-92. PubMed ID: 3899995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.
    Francken AB; Shaw HM; Accortt NA; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2007 Jun; 14(6):1924-33. PubMed ID: 17357855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser radiation therapy of skin melanoma.
    Wagner RI; Kozlov AP; Moskalik KG
    Strahlentherapie; 1981 Oct; 157(10):670-2. PubMed ID: 7303022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of cutaneous melanoma].
    Nyfors A
    Tidsskr Nor Laegeforen; 1992 Jun; 112(17):2225. PubMed ID: 1523664
    [No Abstract]   [Full Text] [Related]  

  • 14. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
    Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor biology of melanoma nodal metastases.
    Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
    Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hazard rate of recurrence in patients with malignant melanoma.
    Conrad FG; Rossing RG; Allen MF; Bales HR
    Aerosp Med; 1971 Nov; 42(11):1219-25. PubMed ID: 5119694
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.
    Garbe C; Leiter U; Ellwanger U; Blaheta HJ; Meier F; Rassner G; Schittek B
    Cancer; 2003 Apr; 97(7):1737-45. PubMed ID: 12655531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphatic metastases in the parotid region from malignant skin neoplasm of the head: considerations for surgical treatment based on personal clinical experience].
    Tullio A; Bianchi B; Sesenna E
    Acta Otorhinolaryngol Ital; 2001 Feb; 21(1):44-9. PubMed ID: 11434222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.